Results summary | View all lists in GO:BiolProc | View all genes in R01AD.profile.ud50 |
The cascade of processes by which a signal interacts with a receptor, causing a change in the level or activity of a second messenger or other downstream target, and ultimately effecting a change in the functioning of the cell. enrichment: 1.59-fold |
![]() |
![]() | |||||||||||
Probe ID | Name | G | T | D | X | E | P | R | C | S | ![]() |
![]() |
Description |
202973_X_AT | FAM13A1 | S | ![]() |
![]() |
family with sequence similarity 13, member A1 | ||||||||
210367_S_AT | PTGES | E | S | ![]() |
![]() |
prostaglandin E synthase | |||||||
203761_AT | SLA | S | ![]() |
![]() |
Src-like-adaptor | ||||||||
203140_AT | BCL6 | G | D | X | R | C | S | ![]() |
![]() |
B-cell CLL/lymphoma 6 (zinc finger protein 51) | |||
203543_S_AT | KLF9 | D | R | S | ![]() |
![]() |
Kruppel-like factor 9 | ||||||
207556_S_AT | DGKZ | S | ![]() |
![]() |
diacylglycerol kinase, zeta 104kDa | ||||||||
205440_S_AT | NPY1R | E | S | ![]() |
![]() |
neuropeptide Y receptor Y1 | |||||||
217739_S_AT | PBEF1 | G | C | S | ![]() |
![]() |
pre-B-cell colony enhancing factor 1 | ||||||
202861_AT | PER1 | R | S | ![]() |
![]() |
period homolog 1 (Drosophila) | |||||||
204526_S_AT | TBC1D8 | G | S | ![]() |
![]() |
TBC1 domain family, member 8 (with GRAM domain) | |||||||
211668_S_AT | PLAU | X | P | S | ![]() |
![]() |
plasminogen activator, urokinase | ||||||
217838_S_AT | EVL | T | D | X | P | S | ![]() |
![]() |
Enah/Vasp-like | ||||
209185_S_AT | IRS2 | G | D | E | S | ![]() |
![]() |
insulin receptor substrate 2 | |||||
203373_AT | SOCS2 | G | S | ![]() |
![]() |
suppressor of cytokine signaling 2 | |||||||
207980_S_AT | CITED2 | D | R | S | ![]() |
![]() |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 | ||||||
203542_S_AT | KLF9 | D | R | S | ![]() |
![]() |
Kruppel-like factor 9 | ||||||
205251_AT | PER2 | R | S | ![]() |
![]() |
period homolog 2 (Drosophila) | |||||||
203108_AT | GPRC5A | S | ![]() |
![]() |
G protein-coupled receptor, family C, group 5, member A | ||||||||
210214_S_AT | BMPR2 | G | D | P | S | ![]() |
![]() |
bone morphogenetic protein receptor, type II (serine/threonine kinase) | |||||
36829_AT | PER1 | R | S | ![]() |
![]() |
period homolog 1 (Drosophila) | |||||||
203685_AT | BCL2 | G | T | X | S | ![]() |
![]() |
B-cell CLL/lymphoma 2 | |||||
202670_AT | MAP2K1 | P | S | ![]() |
![]() |
mitogen-activated protein kinase kinase 1 | |||||||
200878_AT | EPAS1 | D | X | R | S | ![]() |
![]() |
endothelial PAS domain protein 1 | |||||
209121_X_AT | NR2F2 | D | E | R | S | ![]() |
![]() |
nuclear receptor subfamily 2, group F, member 2 | |||||
205486_AT | TESK2 | G | P | C | S | ![]() |
![]() |
testis-specific kinase 2 | |||||
201976_S_AT | MYO10 | S | ![]() |
![]() |
myosin X | ||||||||
204000_AT | GNB5 | S | ![]() |
![]() |
guanine nucleotide binding protein (G protein), beta 5 | ||||||||
201502_S_AT | NFKBIA | G | T | D | S | ![]() |
![]() |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | |||||
204924_AT | TLR2 | G | X | S | ![]() |
![]() |
toll-like receptor 2 | ||||||
208937_S_AT | ID1 | D | R | S | ![]() |
![]() |
inhibitor of DNA binding 1, dominant negative helix-loop-helix protein | ||||||
205067_AT | IL1B | G | X | P | C | S | ![]() |
![]() |
interleukin 1, beta | ||||
209184_S_AT | IRS2 | G | D | E | S | ![]() |
![]() |
insulin receptor substrate 2 | |||||
39402_AT | IL1B | G | X | P | C | S | ![]() |
![]() |
interleukin 1, beta |